Keywords: HCC; Hepatocellular carcinoma; Personalized medicine; Sorafenib; Biomarkers; Molecular marker based-therapy; Individualized therapy; HCC; hepatocellular carcinoma; ICC; intrahepatic cholangiocarcinoma; PCNA; proliferating cell nuclear antigen; CIN; chromosomal
مقالات ISI HCC (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: HCC; HCC; hepatocellular carcinoma; SNPs; single nucleotide polymorphisms; HR; hazard ratio; CI; confidence interval;
Keywords: HCC; HCC; hepatocellular carcinoma; DEB-TACE; doxorubicin-eluted bead based transarterial chemoembolization; P-CT; perfusion-CT; ALP; arterial liver perfusion; PLP; portal venous perfusion; HPI; hepatic perfusion index; AASLD; American Association for the Stud
Keywords: HCC; CI; confidence interval; CLF; chronic liver failure; HCC; hepatocellular carcinoma; LT; liver transplant;
Keywords: HCC; prostatic neoplasms; biopsy; mass screening; Medicaid; African Americans; ASC; ambulatory surgical center; CMS; Centers for Medicare and Medicaid Services; HCC; Hierarchical Condition Category; mpMRI; multiparametric magnetic resonance imaging; PSA; prost
Keywords: HCC; Hepatocellular carcinoma; Pulmonary metastasis; Pulmonary metastasectomy; Liver resection; PM; pulmonary metastasis; HCC; hepatocellular carcinoma; PMT; pulmonary metastasectomy; LR; liver resection; PSM; propensity score matching; OS; overall survival; A
Alarmins in chronic noncommunicable diseases: Atherosclerosis, diabetes and cancer
Keywords: HCC; Alarmins; Proteomics; Atherosclerosis; Diabetes; Cancer; HSPs; heat shock proteins family; HMGB1; high-mobility group box 1; PRR; pattern recognition receptor; PAMP; pathogen-associated molecular pattern; CAD; coronary artery disease; SMC; smooth muscle c
Keywords: HCC; Adenoma; cirrhosis; FNH; HCC; liver; mass; segmental atrophy;
Keywords: HCC; Colorectal cancer; Surgery; liver metastasis; Preclinical; Clinical; Tumor growth; bFGF; basic fibroblast growth factor; CSC; cancer stem cell; CT; computed tomography; EMT; epithelial to mesenchymal transition; HCC; hepatocellular carcinoma; HGF; hepatoc
Keywords: HCC; HCC; Hepatocellular carcinoma; DH; Dysplastic hepatocytes; Mdm2; Mouse double minute 2; PFT; Pfithrin-α; PH; Primary hepatocytes; HBSS; Hank's balanced salt solution; EDTA; Ethylenediaminetetraacetic acid; BSA; Bovine serum albumin; FACS; Fluorescence ac
Keywords: HCC; acc; accuracy; DEG; differentially expressed gene; f1; harmonic mean of precision and sensitivity; HC; hypertrophic compounds; HCC; hypertrophic carcinogenic compounds; HNCC; hypertrophic non-carcinogenic compounds; NHC; non-liver hypertrophic compounds;
Keywords: HCC; HCC; hepatocellular carcinoma; MVI; microvascular invasion; HBsAg; hepatitis B surface antigen; ALT; alanine aminotransferase; TB; total bilirubin; ALB; serum albumin; GGT; gamma glutamyl transpeptidase; AFP; alpha-fetoprotein; PLT; platelet count; CECT;
Keywords: HCC; AFP change; Prognosis; HCC; Hepatectomy; Milan criteria;
Keywords: HCC; ASA; American Society of Anesthesiologists; BBT; benign-borderline tumor; HCC; hepatocellular carcinoma; LD; living donor; LLS; left lateral sectionectomy; PVE; portal vein embolization;
Keywords: HCC; 1H NMR; proton nuclear magnetic resonance; HCC; Hepatocellular carcinoma; HBV; Hepatitis B virus; HCV; Hepatitis C virus; NOESY; Nuclear Overhauser enhancement spectroscopy; LDL; Low density lipoprotein; JUTH; Jos University Teaching Hospital; US; Ultraso
Keywords: HCC; CCA; common carotid artery; CFA; common femoral artery; DEN; diethylnitrosamine; HCC; hepatocellular carcinoma;
Keywords: HCC; Fontan circulation; congestive hepatopathy; hepatic fibrosis; congenital heart disease; adult congenital heart disease; AARCC; Alliance for Adult Research in Congenital Cardiology; ALT; alanine aminotransferase; AST; aspartate aminotransferase; CT; comput
Keywords: HCC; ALBI; albumin-bilirubin; BCLC; Barcelona Liver Clinic Cancer; CI; confidence interval; CPC; Child-Pugh class; HCC; hepatocellular carcinoma; N/A; not applicable; PALBI; platelet-bilirubin-albumin; 90Y; yttrium-90;
Keywords: HCC; CI; confidence interval; HCC; hepatocellular carcinoma; HR; hazard ratio; IPTW; inverse probability of treatment weight; IQR; interquartile range; OLT; orthotopic liver transplantation; OS; overall survival; PFS; progression-free survival; PS; propensity
Keywords: HCC; Milan criteria; Liver function; Prognosis; Resection extent; UICC stage; HCC; hepatocellular carcinoma; FFP; fresh frozen plasma; PEI; percutaneous ethanol injection; PRBCs; packed red blood cells; TACE; transcatheter arterial chemoembolization;
Keywords: HCC; ACP; academic cancer program; AFP; alpha-fetoprotein; AJCC; American Joint Committee on Cancer; CCCP; comprehensive community cancer program; CCP; community cancer program; HCC; hepatocellular carcinoma; HVCP; high volume cancer program; INR; internationa
Keywords: HCC; ASGPR1; Biomarker; Cancer; CCA; CD147; CD326; EMMPRIN; EpCAM; Extracellular vesicles; HCC; Microparticles; Microvesicles;
Keywords: HCC; AFP; alpha-fetoprotein; CLD; cirrhosis/chronic liver disease; HCC; Hepatocellular Carcinoma; HBV; chronic hepatitis B virus; HCV; chronic hepatitis C virus; OPN; Osteopontin; AFP-L3; lectin-bound AFP; DCP; des-γ-carboxy prothrombin; GPC-3; glypican-3; DK
Keywords: HCC; ALT; alanine aminotransferase; BCLC; Barcelona Clinic Liver Cancer; CTCAE; Common Terminology Criteria for Adverse Events; HCC; hepatocellular carcinoma; OR; odds ratio; PES; postembolization syndrome;
Keywords: HCC; AFP; alpha fetoprotein; ECS; embryonal cell sarcoma; HAT; hepatic artery thrombosis; HB; hepatoblastoma; HCC; hepatocellular carcinoma; MPPHT; malignant primary pediatric hepatic tumor; PRETEXT; PRE-Treatment EXT-ension; SIOPEL; International Society of P
Keywords: HCC; CTL; cytotoxic T cells; HCC; hepatocellular carcinomas; HSC; hepatic stellate cells; LSEC; liver sinusoidal endothelial cells; MDSC; myeloid-derived suppressor cells; NASH; non-alcoholic steatohepatitis; NK cells; Natural Killer cells; TAM; tumor-associat
Keywords: HCC; APM; alternative payment model; CMS; Centers for Medicare and Medicaid Services; ESCO; ESRD Seamless Care Organization; ESRD; end-stage renal disease; HCC; hepatocellular carcinoma; MACRA; Medicare Access and CHIP Reauthorization Act;
Keywords: HCC; ATDC; after top dead center; CA; crank angle; CA10; crank angle of 10% mass fraction burned; CA50; crank angle of 50% mass fraction burned; CN; cetane number; DI; direct injected; DISOI; direct injection start of injection; DOI; duration of injection; EGR
Keywords: HCC; HCC; hepatocellular carcinoma; 125I; iodine-125; PVFV; portal vein flow volume; PVTT; portal vein tumor thrombosis; RILD; radiation-induced liver disease;
Keywords: HCC; ALP; alkaline phosphatise; ALT; alanine aminotransferase; ANA; anti-nuclear antibody; anti-LKM1; anti-liver kidney microsomal antibody type1; ASMA; anti-smooth muscle antibody; AST; aspartate aminotransferase; HCC; hepatocellular carcinoma; MPCT; multipha
Keywords: HCC; AFP; α-fetoprotein; ALTSG; American Liver Tumor Study Group; B-UCSF; beyond University of California San Francisco criteria; HCC; hepatocellular carcinoma; LRT; locoregional therapy; LT; liver transplantation; MELD; Model for End-Stage Liver Disease; RFA
Keywords: HCC; Macrophage; Monocyte; Kupffer cell; Liver fibrosis; NASH; Chemokine; HCC; Cholestasis; HBV; HCV;
Keywords: HCC; CN; complete necrosis; FFPE; formalin-fixed, paraffin-embedded; HCC; hepatocellular carcinoma; HR; hazard ratio; LRT; locoregional therapy; MELD; Model for End-Stage Liver Disease; NN; non-necrosis; OLT; orthotopic liver transplantation; PN; partial necro
Keywords: HCC; Cancer; Bio-therapy; Bacterial vectors; Tumor suppression; Immune response; BC; breast cancer; CC; cervical cancer; CMV; cytomegalovirus; CRC; colorectal cancer; HCC; hepatocellular cancer; Hly; hemolysin, an exotoxin produced by bacteria.; HSC; hematopoi
Keywords: HCC; Hepatocellular carcinoma; HCC; Screening; Surveillance; Ultrasound; Reporting;
Keywords: HCC; Immune Checkpoint; Virtual Microdissection; Molecular Subgroups; Immune Regulation; CCL; chemokine (C-C motif) ligand; CTNNB1; catenin beta 1; CXCL; chemokine (C-X-C motif) ligand; FDR; false discovery rate; FF; fresh frozen; FFPE; formalin-fixed paraffin
Keywords: HCC; Liver Cancer; TGFB1; Kras; Zebrafish; α-SMA; α-smooth muscle actin; cDNA; complementary DNA; dox; doxycycline; EGFP; enhanced green fluorescence protein; Gfap; glial fibrillary acidic protein; HCC; hepatocellular carcinoma; HSC; hepatic stellate cell; H
Keywords: HCC; HCC; hepatocellular carcinoma; SNS; sympathetic nervous system; KCs; Kupffer cells; TH; tyrosine hydroxylase; AR; adrenergic receptor; DEN; diethylnitrosamine; 6-OHDA; 6-hydroxydopamine; GdCl3; gadolinium (III) chloride; IL-1α; interleukin-1 alpha; IL-1Î
Keywords: HCC; HCC; hepatocellular carcinoma; HBV; hepatitis B virus; FFPE; formalin-fixed paraffin-embedded; IOD; integral optic density; OS; overall survival; TTR; time-to-recurrence; Hepatocellular carcinoma; Caprin1; Overall survival; Time to recurrence; Prognosis;
Keywords: HCC; Liver Cancer; HCC; Tumor Metabolism; EMT; epithelial to mesenchymal transition; FA; fatty acid; HCC; hepatocellular carcinoma; logFC; log of fold change; NAFLD; nonalcoholic fatty liver disease; NASH; nonalcoholic steatohepatitis; NB; nucleotide biosynthe
Keywords: HCC; UNOS/OPTN; Database; Liver Cancer; LT; BMI; body mass index; CI; confidence interval; DAA; direct antiviral agent; HCC; hepatocellular carcinoma; HBV; hepatitis B virus; HCV; hepatitis C virus; HR; hazard ratio; LT; liver transplantation; MELD; Model for
Keywords: HCC; liver tumor; mortality; reduction; risk factor; AFP; alpha-fetoprotein; AOR; adjusted odds ratio; CI; confidence interval; HBV; hepatitis B virus; HCV; hepatitis C virus; HCC; hepatocellular carcinoma; HR; hazard ratio; MHT; menopausal hormonal therapy; O
Keywords: HCC; HCC; Robotic liver surgery; MILS; da Vinci; Patient safety; Surgical education;
Keywords: HCC; Liver Cancer; Aspergillus; Risk Factor; Pathogenesis; AA; aristolochic acid; AFB1; aflatoxin B1; AF-HCC; aflatoxin-associated hepatocellular carcinoma; CBS; cohesin-binding site; CTCF; CCCTC-binding factor; HBV; hepatitis B virus; HCC; hepatocellular carc
Keywords: HCC; Gender Disparity; Organ Size; UNOS; Organ Procurement and Transplantation Network; BMI; body mass index; BSA; body surface area; CI; confidence interval; DSA; donor service area; ELV; estimated liver volume; ELW; estimated liver weight; HCC; hepatocellula
Keywords: HCC; Elderly donors; Extended criteria donors; Marginal donors; Liver transplantation; MELD; Model of end stage liver disease; ROS; Oxygen free radicals; ER; Endoplasmic reticulum; DAMP's; Danger associated molecular pattern's; KC's; Kupffer cells; TLR-4; Roll
Keywords: HCC; Liver Cancer; Next-Generation Sequencing; Patient-Derived Cell Lines; Targeted Therapy; AFP; α-fetoprotein; FGFR; fibroblast growth factor receptor; HBV; hepatitis B virus; HCC; hepatocellular carcinoma; IC50; 50% inhibitory concentration; ITH; intratumo
Comprehensive qualification and quantification of triacylglycerols with specific fatty acid chain composition in horse adipose tissue, human plasma and liver tissue
Keywords: HCC; UPLC-ESI-MS; Isomer TGs; Isobaric interference; Oxidized TGs; HCC;
Keywords: HCC; Liver Cancer; Risk Factors; Prognosis; Predicted Outcome; BCLC; Barcelona Clinic Liver Cancer; ECOG; Eastern Cooperative Oncology Group; HBV; hepatitis B virus; HCC; hepatocellular carcinoma; HCV; hepatitis C virus; HKLC; Hong Kong Liver Cancer; IAT; intr
Keywords: HCC; AAPC; average annual percentage change; CRLM; colorectal liver metastases; HCC; hepatocellular carcinoma; LLR; laparoscopic liver resection; PS; posterosuperior segments;